Campbell & CO Investment Adviser LLC Meridian Bioscience Inc Transaction History

Campbell & CO Investment Adviser LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$23.75 - $31.69 $170,168 - $227,058	7,165 Added 55.92%	19,978 $608,000
Q1 2022 May 09, 2022	BUY	$19.97 - $26.94 $34,208 - $46,148	1,713 Added 15.43%	12,813 $333,000
Q4 2021 Feb 10, 2022	BUY	$17.46 - $21.61 $4,190 - $5,186	240 Added 2.21%	11,100 $226,000
Q3 2021 Nov 10, 2021	BUY	$17.35 - $22.5 $188,421 - $244,350	10,860 New	10,860 $209,000
Q4 2020 Feb 09, 2021	SELL	$15.73 - $21.66 $192,582 - $265,183	-12,243 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$13.54 - $26.41 $165,770 - $323,337	12,243 New	12,243 $208,000
Q1 2020 Apr 29, 2020	SELL	$5.57 - $11.5 $114,379 - $236,152	-20,535 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$7.9 - $10.14 $162,226 - $208,224	20,535 New	20,535 $201,000
Q4 2018 Feb 08, 2019	SELL	$14.52 - $19.72 $163,582 - $222,165	-11,266 Closed	0 $0
Q3 2018 Nov 08, 2018	BUY	$14.85 - $16.35 $167,300 - $184,199	11,266 New	11,266 $168,000
Q2 2018 Jul 13, 2018	SELL	$13.8 - $16.8 $215,556 - $262,416	-15,620 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$13.8 - $16.2 $215,556 - $253,044	15,620 New	15,620 $222,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Campbell & CO Investment Adviser LLC, based on Form 13F filings with the SEC.

Stay updated on Campbell & CO Investment Adviser LLC with notifications on news.